Products & Services · Cost of Sales
Unituxin — Cost of Sales
United Therapeutics Unituxin — Cost of Sales decreased by 15.3% to $5.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.8%, from $5.20M to $5.00M. Over 4 years (FY 2021 to FY 2025), Unituxin — Cost of Sales shows an upward trend with a 5.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2017
Last reportedQ1 2026
Rolls up toTotal Cost of Revenue
How to read this metric
An increase relative to revenue suggests margin compression, while a decrease suggests improved manufacturing efficiency or economies of scale.
Detailed definition
This metric captures the direct costs associated with producing and delivering a specific pharmaceutical product to mark...
Peer comparison
Standardized as 'Cost of Goods Sold' (COGS) for specific business segments across the life sciences industry.
Metric ID:
uthr_segment_unituxin_cost_of_salesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | $2.40M | $3.20M | $3.30M | $3.50M | $2.70M | $3.60M | $4.70M | $2.70M | $4.10M | $5.00M | $3.60M | $3.80M | $4.80M | $2.20M | $5.20M | $2.80M | $3.60M | $5.90M | $5.00M |
| QoQ Change | — | -52.0% | +33.3% | +3.1% | +6.1% | -22.9% | +33.3% | +30.6% | -42.6% | +51.9% | +22.0% | -28.0% | +5.6% | +26.3% | -54.2% | +136.4% | -46.2% | +28.6% | +63.9% | -15.3% |
| YoY Change | — | — | — | — | -30.0% | +12.5% | +12.5% | +42.4% | -22.9% | +51.9% | +38.9% | -23.4% | +40.7% | +17.1% | -56.0% | +44.4% | -26.3% | -25.0% | +168.2% | -3.8% |
Range$2.20M – $5.90M
CAGR+0.0%
Avg YoY Growth+15.1%
Median YoY Growth+12.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's unituxin — cost of sales?
- United Therapeutics (UTHR) reported unituxin — cost of sales of $5.00M in Q1 2026.
- How has United Therapeutics's unituxin — cost of sales changed year-over-year?
- United Therapeutics's unituxin — cost of sales decreased by 3.8% year-over-year, from $5.20M to $5.00M.
- What is the long-term trend for United Therapeutics's unituxin — cost of sales?
- Over 4 years (2021 to 2025), United Therapeutics's unituxin — cost of sales has grown at a 5.4% compound annual growth rate (CAGR), from $14.20M to $17.50M.
- What does unituxin — cost of sales mean?
- The direct costs incurred to manufacture and supply a specific product.